Nolvadex -D 20 mg Film- coated tablet
PDF Leaflet Revision Date: 15 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of breast cancer.
Dosage (summary)
20-40 mg daily, in divided doses or as a single dose.
Special Populations
- Elderly
- Women of childbearing potential
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during lactation.
Key Drug Interactions
- Coumarin-type anticoagulants
- CYP2D6 inhibitors
- CYP3A4 inducers
Contraindications
- Pregnancy
- Hypersensitivity to ingredients
Common side effects
- Hot flushes
- Nausea
- Fatigue
- Vaginal bleeding
Counselling Points
- Avoid pregnancy during treatment and for 9 months after
- Monitor for abnormal gynaecological symptoms
Serious warnings
- Increased risk of endometrial cancer
- Risk of thromboembolic events
Important Disclaimer
The Nolvadex -D 20 mg Film- coated tablet professional information leaflet below is the property of Astrazeneca Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
